Helios 50 MW BESS achieves commercial operations in Hokkaido, Japan
TOKYO, Dec. 1, 2025 /PRNewswire/ -- Manoa Energy ("Manoa" or the "Company") today announced the start of commercial operations for the Helios 50MW Battery Energy Storage System ("BESS") in Sapporo City, Hokkaido, Japan. The Helios 50MW / 104 MWh...
YEAHKA's Q3 In-Store E-Commerce Business Sustains Profitability, Partnering with Renowned Brands Such as Midea, Toshiba, and China Telecom
HONG KONG, Nov. 28, 2025 /PRNewswire/ -- YEAHKA Limited (Stock Code: 9923.HK), a leading commerce enablement technology platform, issued a voluntary announcement. The report revealed that the Company's value-added services business continued to...
Singapore businesses lead in AI and data adoption, but face cybersecurity challenges
Strong adoption of AI tools among Singapore businesses Current cybersecurity readiness can be enhanced High AI adoption boosts productivity, but human oversight is essential SINGAPORE, Dec. 1, 2025 /PRNewswire/ -- Singapore businesses are rapidly...
The Science of Longevity: Inside Prof. Mike Chan's Vision for Living Stronger, Smarter, and Longer
BANGKOK, Dec. 1, 2025 /PRNewswire/ -- Malaysia had a rare moment of reflection this year when former Prime Minister Tun Dr. Mahathir Mohamad turned 100. His milestone sparked public conversations about aging, vitality, and what it truly means to...
The Bioregenerative Sports Revolution: How Prof. Mike Chan Is Changing Athlete Recovery -- From Sabah to the Super Bowl
KOTA KINABALU, Malaysia, Dec. 1, 2025 /PRNewswire/ -- Big changes often start in small ways. For Sabah FC, a top Malaysian football club, it began with a simple agreement — a partnership with European Wellness, a medical group best known for...
Perlis Royalty Join Prof. Mike Chan in Strengthening Malaysia's Fight Against Autism
KUALA LUMPUR, Malaysia, Nov. 30, 2025 /PRNewswire/ -- Malaysia's drive to modernize autism care received strong support today when the Raja Muda of Perlis, Tuanku Syed Faizuddin Putra Jamalullail, and his consort, Tuanku Dr. Hajah Lailatul Shahreen...
Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development
- Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC37 oral tablets achieved average absolute oral bioavailability of 4.2%, approximately 9 - , 30 - , and 60-fold higher than semaglutide, tirzepatide, and retatrutide in...
Xinhua Silk Road: Discover China with foreign friends
BEIJING, Nov. 30, 2025 /PRNewswire/ -- Do you want to visit China? How to travel as convenient as a local resident? You can learn from this guide! There are three foreign residents from different countries to show you the mobile payments,...